Key facts
- This page summarizes Dov Bergwerk's Form 4 filing for TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA).
- 2 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 01 Mar 2024, 06:57.
Dov Bergwerk - 28 Feb 2024 Form 4 Insider Report for TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA)
- Reporting relationship
- Acting Chief Legal Officer
- Issuer ticker
- TEVA
- Reported as of
- 28 Feb 2024
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 01 Mar 2024, 06:57:37 UTC
- Prior SEC filing
- 16 Nov 2023
- Source filing
- View source filing
- Reporting owner signature
- /s/ Dov Bergwerk
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Dov Bergwerk filed Form 4 for TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) on 01 Mar 2024.
Change
- Previous filing in this sequence was filed on 16 Nov 2023.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
TEVA
transaction
Ordinary Shares
Options Exercise
- Transaction value
- Shares
- +6,653
- Change %
- +7.4%
- Price
- Shares after
- 96,983
- Date
- 28 Feb 2024
- Ownership
- Direct
- Footnotes
- F1, F2
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
TEVA
transaction
Derivative
Restricted Share Units
Options Exercise
- Transaction value
- $0
- Shares
- -6,653
- Change %
- -100%
- Price
- $0.000000*
- Shares after
- 0
- Date
- 28 Feb 2024
- Ownership
- Direct
- Underlying class
- Ordinary Shares
- Underlying amount
- 6,653
- Exercise price
- Footnotes
- F1, F2, F3
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 3 footnotes
Footnote F1
The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.
Footnote F2
Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share.
Footnote F3
Restricted share units were granted on February 28, 2020, with 6,653 vesting on February 28, 2024.